Semax dosage chart
This summary table compares available dose amounts and schedules by administration route.
| Route | Dose | Frequency & duration |
|---|---|---|
| Intranasal | 300–600 mcg/day | 1-2 times daily · 4-12 weeks |
| Injectable | ~300 mcg | Daily · 4–12 wk |
Semax dosage by administration route
Semax intranasal dosage
Reported intranasal protocols use 300–600 mcg per day, divided across 1-2 administrations daily for 4-12 weeks.[1][2][3]
Semax is an ACTH-fragment analogue associated with neurotrophic and stress-response signaling. Nasal formulations have their own concentrations and delivery volumes.[2][3][4]
Semax injectable dosage
Reported-use amounts for Semax are ~300 mcg per administration, daily, for 4–12 wk. Another reported once-daily subcutaneous progression uses 200 mcg in weeks 1–2, 300 mcg in weeks 3–4, 400 mcg in weeks 5–6 and 500 mcg in weeks 7–12. The same source also lists a separate 6–8-week course followed by 2–4 weeks off; these are not nasal-product directions.[11][12]
Injectable Semax is a separate preparation of the ACTH-fragment analogue. Nasal concentration and spray volume do not define an injectable amount.[2][3][4][11]
Semax dosage calculator
Convert your chosen Semax amount into volume and U-100 syringe units. Adjust the inputs to match your vial and preparation.
Semax safety and side effects
Stacks that include Semax
Open a stack dosage guide for its component amounts, schedules and supporting information.
For a blend calculation, each component's amount and the final volume must be known. A total blend weight alone cannot tell you the dose of each component.
Common Semax dosage questions
Is the listed Semax amount a daily total?
What dosage is listed for Semax?
Sources
Show citationsHide citations
- [1]Search Drugs@FDA for SemaxU.S. Food and Drug Administration. database query.
- [2]Semax, an analog of ACTH((4-7)), regulates expression of immune response genes during ischemic brain injury in rats.Mol Genet Genomics, 2017 Jun. animal.
- [3]Novel Insights into the Protective Properties of ACTH((4-7))PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia-Reperfusion in Rats.Genes (Basel), 2020 Jun 22. animal.
- [4]Semax, synthetic ACTH(4-10) analogue, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure in white rats.Neuropeptides, 2021 Apr. animal.
- [5]Brain Protein Expression Profile Confirms the Protective Effect of the ACTH((4-7))PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia-Reperfusion.Int J Mol Sci, 2021 Jun 8. animal.
- [6][Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia].Zh Nevrol Psikhiatr Im S S Korsakova, 2008. human clinical.
- [7]Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity.Protein Pept Lett, 2018. review.
- [8]Compounding and the FDA: Questions and AnswersU.S. Food and Drug Administration. official guidance.
- [9]Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C ActU.S. Food and Drug Administration, 2026-05-14. official guidance.
- [10]Bulk Drug Substances Used in Compounding Under Section 503B of the FD&C ActU.S. Food and Drug Administration, 2025-01-07. regulatory.
- [11]PepFlow peptide cheat sheet — reported-use and product-orientation reference (not clinical research)PepFlow. reference catalog.
- [12]Semax — Everything Peptide reported protocol (educational reference, not clinical evidence)Everything Peptide. reference catalog.


